ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders	Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Cognition Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Dyskinesias, Huntington disease, Neurologic Manifestations, Nutritional and Metabolic Diseases, Orofacial Dyskinesia, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Wilson disease, atactic disorder, non-human animal, basal ganglia disorder, brain disorder, central nervous system disorder, choreatic disease, cognitive disorder, dementia, drug-induced dyskinesia, dystonic disorder, essential tremor, hereditary disease, inborn errors of metabolism, inborn metal metabolism disorder, inherited neurodegenerative disorder, liver disorder, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy, tardive dyskinesia	Active, not recruiting	Not applicable	2025-05-01		NCT02252380

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
InSightec	28

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Sunnybrook Health Sciences Centre	Toronto	Canada	167
Toronto Western Hospital	Toronto	Canada	44